Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $71.33 USD
Change Today +1.72 / 2.47%
Volume 695.2K
Q On Other Exchanges
New York
As of 8:04 PM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

quintiles transnational hold (Q) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/29/15 - $80.45
52 Week Low
10/15/14 - $51.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

quintiles transnational hold (Q) Related Businessweek News

No Related Businessweek News Found

quintiles transnational hold (Q) Details

Quintiles Transnational Holdings Inc., through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through two segments, Product Development and Integrated Healthcare Services. The Product Development segment offers project management and clinical monitoring services, including study design and operational planning, investigator/site recruitment, site and regulatory start up, patient recruitment, clinical monitoring, and project management for conducting various multi-site trials; and clinical trial support services comprising clinical data management, biostatistical, central laboratories, genomic laboratory, bioanalytical laboratories, cardiac safety and ECG, safety and pharmacovigilance, and phase I clinical pharmacology services. This segment also provides strategic planning and design services for biomarkers, genomics, and personalized medicine, as well as offers model-based drug development and regulatory affairs services; and consulting services, such as product development strategy, regulatory and compliance, and process and IT implementation consulting services. The Integrated Healthcare Services segment offers commercial services comprising contract sales, market entry/market exit, integrated channel management, patient engagement, and market access and commercialization consulting services; real-world late phase services, such as observational studies, comparative effectiveness studies, and product and disease registry services; and communication and health engagement services, including digital patient, and brand and scientific communications services. The company serves biopharmaceutical companies, including medical device and diagnostics companies. Quintiles Transnational Holdings Inc. was founded in 1982 and is based in Durham, North Carolina.

32,600 Employees
Last Reported Date: 03/16/15
Founded in 1982

quintiles transnational hold (Q) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.0M
Executive Chairman
Total Annual Compensation: $800.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $580.0K
Executive Vice President, General Counsel and...
Total Annual Compensation: $434.4K
Compensation as of Fiscal Year 2014.

quintiles transnational hold (Q) Key Developments

Quintiles Transnational Holdings Inc. Elects Annie Hai-Yuan Lo to Board of Directors

Quintiles Transnational Holdings Inc. announced that Annie Hai-yuan Lo, has been appointed to its Board of Directors, effective immediately. Ms. Lo will also serve as a member of the Audit Committee of the Board. Ms. Lo has more than 30 years of financial and operational experience at Johnson & Johnson, a global healthcare company, most recently serving as the Chief Financial Officer of the Worldwide Consumer & Personal Care Group from 2001 until her retirement in 2011. Ms. Lo serves as a director of Ansell Ltd., and TransForce Inc.

Quintiles Transnational Plans Acquisitions

Quintiles Transnational Holdings Inc. (NYSE:Q) intends to make acquisitions. Kevin Gordon, Enterprise Vice President, Operations and Chief Financial Officer of the company said: “Quintiles has always been acquisitive. We're always looking for capability enhancing acquisitions. So even within the lab itself, prior to entering the JV, we did bring in the genomics capability through the acquisition of Expression Analysis. We brought in bioanalytical capability through the acquisition of Advion. We have expanded that capability in Europe as well within the last year. So we've always had a view toward continuing to make sure we have a full suite of service offering in our lab.”

Quintiles Transnational Holdings Inc. Presents at UBS Best of Americas 2015 Conference, Sep-11-2015 09:00 AM

Quintiles Transnational Holdings Inc. Presents at UBS Best of Americas 2015 Conference, Sep-11-2015 09:00 AM. Venue: UBS Offices, 1 Finsbury Avenue, London, United Kingdom. Speakers: Thomas H. Pike, Chief Executive Officer and Director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
Q:US $71.33 USD +1.72

Q Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $64.51 USD +1.42
ICON PLC $72.25 USD +0.14
IMS Health Holdings Inc $29.50 USD +0.60
PAREXEL International Corp $61.33 USD +0.36
PRA Health Sciences Inc $39.54 USD +0.68
View Industry Companies

Industry Analysis


Industry Average

Valuation Q Industry Range
Price/Earnings 26.0x
Price/Sales 2.1x
Price/Book NM Not Meaningful
Price/Cash Flow 24.8x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUINTILES TRANSNATIONAL HOLD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at